Clinical Investigation To Evaluate Cerviron Ovules® in Cervix Lesions Postoperative Care

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

January 6, 2023

Study Completion Date

January 16, 2023

Conditions
Cervical Lesion
Interventions
DEVICE

Cerviron

"Cerviron® ovules is a class IIb medical device used as adjuvant treatment in cervical lesions of mechanical origin. It favors the healing and re-epithelialization processes and reduces the proliferation of endogenous pathogens.~Moreover, it provides a strong hemostatic effect, as shown in multiple studies. Moreover, it contains collagen with nutritive, hydrating, healing and trophic effect. Collagen is structurally and functionally a key protein of the extracellular matrix which is also involved in forming the scars during the healing of conjunctive tissues, due to its chemotactic role. Many collagen bandages were developed to improve the repair of the wound, especially of non-infected, chronic, idle cutaneous ulcerations."

Trial Locations (3)

Unknown

"Institutul National pentru Sanatatea Mamei si Copilului Alessandrescu-Rusescu", Bucharest

Centrul Medical MIȘCĂ, Timișoara

"Spitalul Clinic Județean de Urgență Pius Brinzeu", Timișoara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

MDX Research

NETWORK

lead

Perfect Care Distribution

INDUSTRY

NCT04735718 - Clinical Investigation To Evaluate Cerviron Ovules® in Cervix Lesions Postoperative Care | Biotech Hunter | Biotech Hunter